glp 1 agonist action Possible mechanisms of of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight Evolution of GLP‐1 Receptor Agonists

They can improve weight loss and health and reduce mortality

Short-chain fatty acids and regulation of pancreatic endocrine secretion in mice

Balk-Mller E, Windelv JA, Svendsen B, Hunt J, Ghiasi SM, Srensen CM, et al

Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, et al

Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al

(Medicare Policy Initiative) Pilot programs: There have been reports that experiments or pilot programs are being considered to allow Medicare and Medicaid to better cover GLP-1s for obesity (possibly starting 2026/2027) in certain states or under certain conditions